Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001218629-26-000002

Bd. Co-Chair, President & CEO gave up 28,570 shares (to pay taxes)

  • Bd. Co-Chair, President & CEO acquired 28,570 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SCHLEIFER LEONARD S · Bd. Co-Chair, President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-31 Exercise or conversion : show line 1 in the form +28,570 243,093 D
2025-12-31 Shares withheld for taxes : show line 2 in the form −28,570 $772.09 $22,058,611 214,523 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-31 Exercise or conversion : show line 3 in the form 2020 Performance Stock Units −28,570 595,077 D
Loading xslF345X05/edgardoc.xml…